{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T06:04:03Z","timestamp":1794895443911,"version":"4.9.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["11\/Y\/B2093"],"award-info":[{"award-number":["11\/Y\/B2093"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["13\/RC\/2073"],"award-info":[{"award-number":["13\/RC\/2073"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007211","name":"Vasculitis Foundation","doi-asserted-by":"publisher","award":["205178\/13967"],"award-info":[{"award-number":["205178\/13967"]}],"id":[{"id":"10.13039\/100007211","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001590","name":"Health Research Board","doi-asserted-by":"publisher","award":["HRA-POR-2015-1205"],"award-info":[{"award-number":["HRA-POR-2015-1205"]}],"id":[{"id":"10.13039\/501100001590","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001590","name":"Health Research Board","doi-asserted-by":"publisher","award":["NSAFP-2013-02"],"award-info":[{"award-number":["NSAFP-2013-02"]}],"id":[{"id":"10.13039\/501100001590","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001590","name":"Health Research Board","doi-asserted-by":"publisher","award":["203930\/B\/16\/Z"],"award-info":[{"award-number":["203930\/B\/16\/Z"]}],"id":[{"id":"10.13039\/501100001590","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["U54-DK-083912"],"award-info":[{"award-number":["U54-DK-083912"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["JASN"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n                    <jats:title>Significance Statement<\/jats:title>\n                    <jats:p>In ANCA-associated vasculitis (AAV), noninvasive biomarkers of active renal inflammation, such as urinary soluble CD163, are needed for early detection of active disease before irreversible end organ damage occurs. Clinical translation requires a diagnostic-grade assay, prospective assessment of its diagnostic utility in AAV flare, and assessment of its utility in proteinuric states. The authors report use of an accredited, diagnostic-grade assay for urinary soluble CD163, derivation of cutoff values, and application of the assay to a prospective cohort of patients with potential renal vasculitis flare. They found that urinary soluble CD163 displays high precision in separating RV flare from flare mimics. They also observed increased false-positive results in the setting of high-grade proteinuria, which they demonstrated can be effectively corrected by normalization to the urine protein value, thereby restoring diagnostic accuracy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Up to 70% of patients with ANCA-associated vasculitis (AAV) develop GN, with 26% progressing to ESKD. Diagnostic-grade and noninvasive tools to detect active renal inflammation are needed. Urinary soluble CD163 (usCD163) is a promising biomarker of active renal vasculitis, but a diagnostic-grade assay, assessment of its utility in prospective diagnosis of renal vasculitis flares, and evaluation of its utility in proteinuric states are needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We assessed a diagnostic-grade usCD163 assay in (\n                      <jats:italic toggle=\"yes\">1<\/jats:italic>\n                      ) a real-world cohort of 405 patients with AAV and 121 healthy and 488 non-AAV disease controls; (\n                      <jats:italic toggle=\"yes\">2<\/jats:italic>\n                      ) a prospective multicenter study of 84 patients with potential renal vasculitis flare; (\n                      <jats:italic toggle=\"yes\">3<\/jats:italic>\n                      ) a longitudinal multicenter cohort of 65 patients with podocytopathy; and (\n                      <jats:italic toggle=\"yes\">4<\/jats:italic>\n                      ) a cohort of 29 patients with AAV (with or without proteinuria) and ten controls.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We established a diagnostic reference range, with a cutoff of 250 ng\/mmol for active renal vasculitis (area under the curve [AUC], 0.978). Using this cutoff, usCD163 was elevated in renal vasculitis flare (AUC, 0.95) but remained low in flare mimics, such as nonvasculitic AKI. usCD163\u2019s specificity declined in patients with AAV who had nephrotic-range proteinuria and in those with primary podocytopathy, with 62% of patients with nephrotic syndrome displaying a \u201cpositive\u201d usCD163. In patients with AAV and significant proteinuria, usCD163 normalization to total urine protein rather than creatinine provided the greatest clinical utility for diagnosing active renal vasculitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>usCD163 is elevated in renal vasculitis flare and remains low in flare mimics. Nonspecific protein leakage in nephrotic syndrome elevates usCD163 in the absence of glomerular macrophage infiltration, resulting in false-positive results; this can be corrected with urine protein normalization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1681\/asn.2021030382","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T15:45:17Z","timestamp":1631547917000},"page":"2920-2932","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":41,"title":["The Clinical Application of Urine Soluble CD163 in ANCA-Associated Vasculitis"],"prefix":"10.1681","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9377-4133","authenticated-orcid":false,"given":"Sarah M.","family":"Moran","sequence":"first","affiliation":[{"name":"Trinity Health Kidney Centre, Trinity College Dublin, Dublin, Ireland"},{"name":"Department of Medicine, Queen\u2019s University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Scott","sequence":"additional","affiliation":[{"name":"Trinity Health Kidney Centre, Trinity College Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Clarkson","sequence":"additional","affiliation":[{"name":"Cork University Hospital, Ireland, University College Cork, Cork, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1102-0758","authenticated-orcid":false,"given":"Niall","family":"Conlon","sequence":"additional","affiliation":[{"name":"St James\u2019s Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Dunne","sequence":"additional","affiliation":[{"name":"St James\u2019s Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8701-8056","authenticated-orcid":false,"given":"Matthew D.","family":"Griffin","sequence":"additional","affiliation":[{"name":"REMEDI at C\u00daRAM SFI Centre for Research in Medical Devices, School of Medicine, National University of Ireland, Galway, Ireland"},{"name":"Department of Nephrology, Saolta University Health Care Group, Galway University Hospitals, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas P.","family":"Griffin","sequence":"additional","affiliation":[{"name":"REMEDI at C\u00daRAM SFI Centre for Research in Medical Devices, School of Medicine, National University of Ireland, Galway, Ireland"},{"name":"Centre for Endocrinology, Diabetes and Metabolism, Saolta University Health Care Group, Galway University Hospitals, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Groarke","sequence":"additional","affiliation":[{"name":"St James\u2019s Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Holian","sequence":"additional","affiliation":[{"name":"St Vincent\u2019s University Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor","family":"Judge","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Saolta University Health Care Group, Galway University Hospitals, Galway, Ireland"},{"name":"Centre for Endocrinology, Diabetes and Metabolism, Saolta University Health Care Group, Galway University Hospitals, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Wyse","sequence":"additional","affiliation":[{"name":"Discipline of Statistics and Information Systems, Trinity College Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"McLoughlin","sequence":"additional","affiliation":[{"name":"St James\u2019s Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul V.","family":"O\u2019Hara","sequence":"additional","affiliation":[{"name":"Beaumont Kidney Centre, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kretzler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan"},{"name":"Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6003-397X","authenticated-orcid":false,"given":"Mark A.","family":"Little","sequence":"additional","affiliation":[{"name":"Trinity Health Kidney Centre, Trinity College Dublin, Dublin, Ireland"},{"name":"Beaumont Kidney Centre, Dublin, Ireland"},{"name":"Tallaght University Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Nephrotic Syndrome Study Network (NEPTUNE)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,11]]},"reference":[{"key":"B2-20240826","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0272-6386(03)00025-8","article-title":"Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study","volume":"41","author":"Booth","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"B3-20240826","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3899\/jrheum.131038","article-title":"A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis","volume":"41","author":"Mohammad","year":"2014","journal-title":"J Rheumatol"},{"key":"B4-20240826","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ki.2009.218","article-title":"The clinical course of ANCA small-vessel vasculitis on chronic dialysis","volume":"76","author":"Lionaki","year":"2009","journal-title":"Kidney Int"},{"key":"B5-20240826","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2215\/CJN.04710420","article-title":"Systematic review and meta-analysis of native kidney biopsy complications","volume":"15","author":"Poggio","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"B6-20240826","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000449511","article-title":"Renal interstitial fibrosis: an imperfect predictor of kidney disease progression in some patient cohorts","volume":"44","author":"Menn-Josephy","year":"2016","journal-title":"Am J Nephrol"},{"key":"B7-20240826","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2215\/CJN.04160417","article-title":"The utility of urinalysis in determining the risk of renal relapse in ANCA-associated vasculitis","volume":"13","author":"Rhee","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"B8-20240826","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1093\/ndt\/gfw257","article-title":"Urine sCD163: a window onto glomerular inflammation","volume":"31","author":"M\u00f8ller","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"B9-20240826","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1111\/j.1523-1755.2004.00659.x","article-title":"Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes","volume":"65","author":"Weissinger","year":"2004","journal-title":"Kidney Int"},{"key":"B10-20240826","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/ndt\/gfy018","article-title":"Urinary and serum soluble CD25 complements urinary soluble CD163 to detect active renal anti-neutrophil cytoplasmic autoantibody-associated vasculitis: A cohort study","volume":"34","author":"Dekkema","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"B11-20240826","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1182\/blood.V99.1.378","article-title":"Identification of the hemoglobin scavenger receptor\/CD163 as a natural soluble protein in plasma","volume":"99","author":"M\u00f8ller","year":"2002","journal-title":"Blood"},{"key":"B12-20240826","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1182\/blood-2008-07-167064","article-title":"The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria","volume":"113","author":"Fabriek","year":"2009","journal-title":"Blood"},{"key":"B13-20240826","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1681\/ASN.2015050511","article-title":"Urinary soluble CD163 in active renal vasculitis","volume":"27","author":"O\u2019Reilly","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B14-20240826","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/ndt\/gfy300","article-title":"Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"35","author":"Moran","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"B15-20240826","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/ndt\/gfw214","article-title":"Urinary soluble CD163 level reflects glomerular inflammation in human lupus nephritis","volume":"31","author":"Endo","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"B16-20240826","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1681\/ASN.2019121285","article-title":"Urinary soluble CD163: a novel noninvasive biomarker of activity for lupus nephritis","volume":"31","author":"Mejia-Vilet","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"B17-20240826","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"B18-20240826","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.05000516","article-title":"Minimal change disease","volume":"12","author":"Vivarelli","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B19-20240826","doi-asserted-by":"crossref","first-page":"18452","DOI":"10.1038\/s41598-019-54762-2","article-title":"Plasma dephosphorylated-uncarboxylated Matrix Gla-Protein (dp-ucMGP): Reference intervals in Caucasian adults and diabetic kidney disease biomarker potential","volume":"9","author":"Griffin","year":"2019","journal-title":"Sci Rep"},{"key":"B20-20240826","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1515\/cclm-2018-0534","article-title":"Defining reference intervals for a serum growth differentiation factor-15 (GDF-15) assay in a Caucasian population and its potential utility in diabetic kidney disease (DKD)","volume":"57","author":"Hamon","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"B21-20240826","article-title":"Reference intervals for commonly requested biochemical and haematological parameters in a healthy Irish adult Caucasian population","author":"Islam","journal-title":"Ir J Med Sci"},{"key":"B22-20240826","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B23-20240826","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ki.2012.428","article-title":"Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach","volume":"83","author":"Gadegbeku","year":"2013","journal-title":"Kidney Int"},{"key":"B24-20240826","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/annrheumdis-2019-216863","article-title":"Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis","volume":"79","author":"Smith","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B25-20240826","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"B26-20240826","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/003655901753224477","article-title":"Wegener\u2019s granulomatosis: inflammatory cells and markers of repair and fibrosis in renal biopsies--a clinicopathological study","volume":"35","author":"Aasar\u00f8d","year":"2001","journal-title":"Scand J Urol Nephrol"},{"key":"B27-20240826","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1523-1755.2002.00089.x","article-title":"Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups","volume":"61","author":"Hauer","year":"2002","journal-title":"Kidney Int"},{"key":"B29-20240826","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v061.i08","article-title":"OptimalCutpoints: An R package for selecting optimal cutpoints in diagnostic tests","volume":"61","author":"L\u00f3pez-Rat\u00f3n","year":"2014","journal-title":"J Stat Softw"},{"key":"B30-20240826","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"B31-20240826","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"B32-20240826","doi-asserted-by":"crossref","first-page":"46","DOI":"10.21037\/atm.2017.11.37","article-title":"Tutorial: development of an online risk calculator platform","volume":"6","author":"Ji","year":"2018","journal-title":"Ann Transl Med"},{"key":"B33-20240826","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00365513.2011.626868","article-title":"Soluble CD163","volume":"72","author":"M\u00f8ller","year":"2012","journal-title":"Scand J Clin Lab Invest"},{"key":"B34-20240826","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0002-9343(84)90368-1","article-title":"Interpreting the fractional excretion of sodium","volume":"77","author":"Steiner","year":"1984","journal-title":"Am J Med"},{"key":"B35-20240826","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1468-1331.2006.01493.x","article-title":"Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force","volume":"13","author":"Deisenhammer","year":"2006","journal-title":"Eur J Neurol"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.2021030382","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:30:56Z","timestamp":1786131056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.2021030382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2021030382","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740811213.793589138","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.740811213.793589915","asserted-by":"object"}]},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"2021-03-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}